Clinical Trial: Efficacy of Dapagliflozin on Recurrence After Catheter Ablation for Atrial Fibrillation
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Atrial Fibrillation
Study Type: INTERVENTIONAL
Official Title: Efficacy of DApagliflozin on REcurrence After Catheter Ablation for Atrial Fibrillation
Brief Summary:
This is a single-center, parallel-group, randomized, open-label trial evaluating the effect of 3-month treatment with dapagliflozin 10mg once daily on the recurrence of atrial fibrillation after catheter ablation for atrial fibrillation in patients without diabetes, heart failure, or chronic kidney disease.
Read more